Showing results (551-560 of 1,244) with videos related to

Sort By:
Pageof 125
Infectious Diseases Now|June 20, 2026
Antibiotic penetration in the male urinary tract: a critical review of pharmacokinetic and pharmacodynamic evidenceAntoine Hamon, Vincent Jullien, Vincent Cattoir, et al.
Development (Cambridge, England)|June 9, 2021
Secreted inhibitors drive the loss of regeneration competence in Xenopus limbsCan Aztekin, Tom W Hiscock, John Gurdon, et al.
Chemical Science|June 14, 2021
Dynamic contrast with reversibly photoswitchable fluorescent labels for imaging living cellsRaja Chouket, Agnès Pellissier-Tanon, Annie Lemarchand, et al.
Eye & Contact Lens|July 17, 2023
Baseline Characteristics of 1976 Patients With Ectatic Corneal Disorders at a Single Center From 2010 to 2021: A Cross-Sectional Study of the Homburg Keratoconus CenterHaris Sideroudi, Elias Flockerzi, Loay Daas, et al.
Proteins|October 29, 2002
Nonatomic solvent-driven Voronoi tessellation of proteins: an open tool to analyze protein foldsBorislav Angelov, Jean-François Sadoc, Rémi Jullien, et al.
BMJ Open|January 26, 2019
Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trialGeraldine Favrais, Moreno Ursino, Catherine Mouchel, et al.
The Review of Scientific Instruments|September 2, 2019
A project of advanced solid-state neutron polarizer for PF1B instrument at Institut Laue-LangevinA K Petukhov, V V Nesvizhevsky, T Bigault, et al.
Annales De L'Anesthesiologie Francaise|January 1, 1980
[Comparison of postoperative blood levels of prolactin and somatotropin after two methods of anesthesia]Y Jullien, M de Rodez, A Bonardet, et al.
British Journal of Clinical Pharmacology|August 4, 2017
Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic childrenChristelle Rodrigues, Catherine Chiron, Elisabeth Rey, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1985
[Two anti-Brucella SF311 and S480 monoclonal antibodies with protective activity against Brucella pathogenic for mice]J P Vendrell, H Rabesandratana, Y Jullien, et al.
Pageof 125